IP Verse

Novel Compounds Having Inhibitory Activity Against Sodium-Dependant Glucose Transporter - EP2896397B2

PatentPatent Analysis

EP2896397

MITSUBISHI TANABE PHARMA
Application Number
EP14194507A
Filing Date
Jul 30, 2004
Status
Patent Maintained As Amended
Sep 4, 2020
Grant Date
Oct 7, 2020
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3875085B1
EP2252289B1
EP2754440B1

Bibliography

The patent EP2896397B2 was granted to Mitsubishi Tanabe Pharma on Oct 7, 2020 following the initial filing on Jul 30, 2004 under the application number EP14194507A . The current legal status of the patent is Patent Maintained As Amended.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GALENICUM HEALTH SLJun 6, 2018ADMISSIBLE
GENERICS UKJun 5, 2018ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents